Keywords: intercell, ixiaro, je, vacc, recommended, eu, approval

Intercell's Ixiaro JE vacc recommended for EU approval

Article | 08 April 2009

Print This

US biotechnology firm Epix Pharmaceuticals has sold the US, Canadian and Australian rights for its blood pool magnetic resonance angiography ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in